[1] Scalera N M, Mossad S B. The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus[J]. Postgrad Med,2009,121(5):43-47. [2] Cauchemez S, Donnelly C A, Reed C,et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States[J]. N Engl J Med,2009,361(27):2619-2627. [3] 祈贤,汤奋扬,李亮,等.新甲型H1N1(2009)流感病毒的早期分子特征[J].微生物学报,2010,50(1):81-90. [4] Lu X, Liu F, Zeng H, et al. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus[J]. Virology, 2014, 454-455: 169-175. [5] 段雪晶,李勇,戴洁,等.重症甲型H1N1流感八例呼吸系统病理学特征分析[J]. 中华病理学杂志,2011,40(12):825-829. [6] Mauad T, Hajjar L A, Callegari GD, et al. Lung pathology in fatal novel human influenza A(H1N1) infection[J]. Am J Respir Crit Care Med,2010,181(1):72-79. [7] Harms P W, Schmidt L A, Smith L B, et al. Autopsy findings in eight patients with fatal H1N1 Influenza[J]. Am J Clin Pathol,2010, 134(1):27-35. [8] Mauad T, Hajjar L A, Callegari G D, et al. Lung pathology in fatal novel human influenza A (H1N1) infection[J]. Am J Respir Crit Care Med, 2010, 181(1):72-79. [9] Harms P W, Schmidt L A, Smith L B, et al. Autopsy findings in eight patients with fatal H1N1 influenza[J]. Am J Clin Path, 2010, 134(1): 27-35. [10] Bal A, Suri V, Mishra B, et al. Pathology and virology findings in cases of fatal influenza A H1N1 virus infection in 2009-2010[J]. Histopathology, 2012, 60(2):326-335. [11] 孟伟民. 甲流重症、 危重症患者T淋巴细胞亚群测定的 临床观察[J].青海医药杂志,2011,41(6):11-12. [12] 陈颖, 王军, 温华,等. 重症甲型H1N1流感患者外周血T淋巴细胞亚群变化的临床意义探讨[J]. 中国医科大学学报, 2011, 40(2):140-143. [13] 李杨, 秦晓松. 甲型H1N1流感患者Th1/Th2细胞因子水平的观察[J]. 中国医科大学学报. 2012,41(8) :753-755. [14] Liu B, Zhang X, Deng W, et al. Severe influenza A(H1N1)pdm09 infection induces thymic atrophy through activating innate CD8(+)CD44(hi) T cells by upregulating IFN-γ[J].Cell Death Differ,2014, 5:e1440. doi: 10.1038/cddis.2014.323. |